Fixed-combination drug beneficial in glaucoma therapy

Groves, Nancy
January 2004
Ophthalmology Times;1/15/2004, Vol. 29 Issue 2, p30
Trade Publication
Investigates the beneficial of the fixed combination of timololdorzolamide in glaucoma therapy. Obstacles in the success of glaucoma therapy; Ability of the timololdorzolamide therapy to reduce IOP; Response of glaucoma patients towards the therapy.


Related Articles

  • Prostaglandin analogs help patients stick with regimen. Guttman, Cheryl // Ophthalmology Times;1/15/2004, Vol. 29 Issue 2, p26 

    Investigates the response of glaucoma patients towards the prostaglandin-type drug treatment. Patients enrolled in the study; Analysis of persistency in relation to the therapy of glaucoma; Comparison of the rate of persistency of patients taking latanoprost with bimatropost and travoprost;...

  • Choice of medication should be determined case by case. Groves, Nancy // Ophthalmology Times;1/15/2004, Vol. 29 Issue 2, p45 

    Investigates the safety and tolerability of prostaglandin analogues as part of a therapeutic regimen for patients with glaucoma. Need for cognition in the choice of medication of glaucoma patients; Potential of prostaglandin analogues in preventing deterioration of the visual field and optic...

  • PARADIGMS IN MEDICAL MANAGEMENT. Gross, Ronald L. // Ophthalmology Times;5/1/2006 Supplement, Vol. 31, p10 

    The article presents the changes in the paradigms for managing glaucoma. Among these are setting the target pressure, which needs the recognition of the importance of individualization based on factors such as the pressure where the damage is occurring, severity of damage and physiologic age and...

  • Glaucoma treatment still poses many obstacles. Charters, Lynda // Ophthalmology Times;1/15/2004, Vol. 29 Issue 2, p22 

    Focuses on the challenges faced by physicians and patients in the treatment of glaucoma. Failure of the ophthalmologists to diagnose the cases of glaucoma; Status of screening for glaucoma; Risk of glaucoma for individuals with ocular hypertension; Treatment noncompliance of patients with...

  • Autoantibody repertoires could be key in glaucoma research. Guttman, Cheryl // Ophthalmology Times;1/15/2004, Vol. 29 Issue 2, p24 

    Determines the usefulness of the analysis of autoantibody repertoires using advanced pattern-matching algorithms for diagnosis of glaucoma. Results of studies showing statistically significant difference in profiles of autoantibodies against retinal, optic nerve, and optic nerve head antigens...

  • Allergic response to brimonidine may remain in other forms. Charters, Lynda // Ophthalmology Times;1/15/2004, Vol. 29 Issue 2, p34 

    Examines the allergic ocular reaction of glaucoma patients to brimonidine. Reliance of the allergic response rate of brimonidine on geography and season; Rate of allergic reaction of glaucoma patients; Patients enrolled in the study.

  • Two bottle limit often defines optimal medical therapy. Guttman, Cheryl // Ophthalmology Times;1/15/2006, Vol. 31 Issue 2, p1 

    The article focuses on optimal medical therapy for patients needing intraoptical pressure-lowering treatment. Correct multi-drug therapy means patients need more than one IOP-lowering drug and all of the medications they are using are appropriate and effective. Ophthalmologists are given tips on...

  • Research advances set glaucoma neuroprotection on horizon. Guttman, Cheryl; Tsai, James C. // Ophthalmology Times;6/15/2004, Vol. 29 Issue 12, p50 

    Reports on the anticipation of development of therapeutics for glaucoma through the research advances in the U.S. Factors contributing to the renewed interest in neuroprotective treatments for glaucoma; Neuroprotective activity of brimonide; Importance of the development of neuroprotective...

  • Glaucoma management update draws from clinical trials. Groves, Nancy; Cioffi, George A.; Fechtner, D.; Parish II, Richard K.; Singh, Kuldev; Weinreb, Robert N. // Ophthalmology Times;6/15/2004, Vol. 29 Issue 12, p52 

    Reports on the glaucoma management updates presented at a symposium sponsored by the Institute for Medical Studies and the periodical "Ophthalmology Times" in the U.S. Development of sophisticated strategies for diagnosing glaucoma and estimating the risk of progression; Identification of the...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics